期刊
NUTRITION
卷 25, 期 11-12, 页码 1206-1211出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.nut.2009.06.014
关键词
Biomarker; Bioactive constituents; Nutraceuticals; Health effect; Xenobiotics; Bioavailability; Intake; Phytochemicals
The efficacy and safety of bioactive compounds depend on a few known and unknown parameters. What is a physiologic dose and how can that dose be defined in cases of bioactive compounds with a poor knowledge of supply and distribution? What safety sets are needed? How can individual aspects such as polymorphisms or differences in absorption be considered? A group of experts tried to answer these and related questions during the 23rd Hohenheim Consensus Meeting at the University of Hohenheim in Stuttgart. (C) 2009 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据